SHP2 potentiates anti-PD-1 effectiveness through intervening cell pyroptosis resistance in triple-negative breast cancer-Reference-Cited by-同舟云学术

SHP2 potentiates anti-PD-1 effectiveness through intervening cell pyroptosis resistance in triple-negative breast cancer

Published:2023-12 Issue: Volume:168 Page:115797
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Chen Chao,Cheng Yuanyuan,Lei Haoqi,Feng Xuefei,Zhang Hongxia,Qi Lingling,Wan Jufeng^ORCID,Xu Haiying,Zhao Xin,Zhang Yan,Yang Baofeng

Funder

Chinese Academy of Meteorological Sciences

Natural Science Foundation of Heilongjiang Province

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference50 articles.

1. Cancer statistics, 2022;Siegel;CA Cancer J. Clin.,2022

2. The landscape of targeted therapies in TNBC;Vagia;Cancers,2020

3. Intrinsic and extrinsic pathways of apoptosis: role in cancer development and prognosis;Kashyap;Adv. Protein Chem. Struct. Biol. 125,2021

4. Elevated methionine flux drives pyroptosis evasion in persister cancer cells;El-Kenawi;Cancer Res.,2023

5. Receptor-binding, tyrosine phosphorylation and chromosome localization of the mouse SH2-containing phosphotyrosine phosphatase Syp;Feng;Oncogene,1994

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell Death: Mechanisms and Potential Targets in Breast Cancer Therapy;International Journal of Molecular Sciences;2024-09-07

2. Design, Synthesis, Antitumor Activity Evaluation, and Molecular Dynamics Simulation of Some 2-Aminopyrazine Derivatives;Current Computer-Aided Drug Design;2024-03-12

3. The low expression of miR-155 promotes the expression of SHP2 by inhibiting the activation of the ERK1/2 pathway and improves cell pyroptosis induced by I/R in mice;Aging;2024-03-06